Infimer Financials
| INFR-M Stock | 199.10 0.20 0.10% |
Infimer |
Understanding current and past Infimer Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Infimer's financial statements are interrelated, with each one affecting the others. For example, an increase in Infimer's assets may result in an increase in income on the income statement.
Please note, the presentation of Infimer's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Infimer's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Infimer's management manipulating its earnings.
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| Business Address | 6 Hashomer Street, |
| Benchmark | Dow Jones Industrial |
| Website | www.infimer.com |
| Phone | 972 4 888 9683 |
You should never invest in Infimer without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Infimer Stock, because this is throwing your money away. Analyzing the key information contained in Infimer's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Infimer Key Financial Ratios
Infimer's financial ratios allow both analysts and investors to convert raw data from Infimer's financial statements into concise, actionable information that can be used to evaluate the performance of Infimer over time and compare it to other companies across industries.Infimer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Infimer's current stock value. Our valuation model uses many indicators to compare Infimer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infimer competition to find correlations between indicators driving Infimer's intrinsic value. More Info.Infimer is currently regarded as number one stock in return on asset category among its peers. It is rated fifth overall in shares owned by insiders category among its peers making about 13.62 of Shares Owned By Insiders per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Infimer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infimer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Infimer Systematic Risk
Infimer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Infimer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Infimer correlated with the market. If Beta is less than 0 Infimer generally moves in the opposite direction as compared to the market. If Infimer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infimer is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infimer is generally in the same direction as the market. If Beta > 1 Infimer moves generally in the same direction as, but more than the movement of the benchmark.
Infimer January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Infimer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Infimer. We use our internally-developed statistical techniques to arrive at the intrinsic value of Infimer based on widely used predictive technical indicators. In general, we focus on analyzing Infimer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Infimer's daily price indicators and compare them against related drivers.
| Downside Deviation | 39.22 | |||
| Information Ratio | 0.1548 | |||
| Maximum Drawdown | 40076.17 | |||
| Value At Risk | (14.20) | |||
| Potential Upside | 59.81 |
Complementary Tools for Infimer Stock analysis
When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |